Health Robotics, a world renowned provider of robotics expertise and automated software solutions for healthcare, has reportedly announced the selection of its Health Robotics' CytoCare Robot by Innomed/BioRobotics to provide a total Cancer Robotic solution.

 

The selection will make Health Robotics to be the model provider of Oncology Robotics IV Admixtures for cancer therapy in Korean republic.  

 

“We are very pleased to reach 100 percent territorial coverage for CytoCare in Asia-Pacific,” Werner Rainer, CEO of Health Robotics said in a statement. “This new partnership culminates a great year for Health Robotics' CytoCare adoption and unprecedented market success versus our competition, on the heels of similar new partnerships signed this Summer and Fall in Oceania, China, Taiwan, and South East Asia.”

 

“In these difficult economic times and at a moment where our competitors are in retreat and total disarray, we have increased our lead in product superiority, expanded our reach worldwide, and are now posed to reap benefits in years to come,” Rainer said. “We welcome BioRobotics to our family of strategic channel partners and look forward to host them next week, along with more than 20 worldwide partners at Health Robotics' First Annual Partner Training in Trieste, Italy.”

 

The robotics systems are designed to fill the gap between the growing volumes suffering patients and meager medical human resource. The systems, while providing ready to administer type of drugs, help to remove the costly anomalies in the preparation of drugs meant for cancer patients.

 

Cytocare Robot system from Health Robotics is used for preparing unsafe IV admixtures for chemotherapy, monoclonal antibody therapy and gene therapy. The system ensures secure and hygienic preparation of the drugs to meet the precise requirements of the cancer patients. Cytocare is the only robotic solution available all over the globe to robotically mix and provide risky type of IV Admixtures in ready to use format.    

 

Innomed/BioRobotics is one of the major medical equipments importing company in Republic of Korea. Started in 1995, BioRobotics was handling laser surgery Cryosurgery equipment segments till 2005 and entered into Oncology Robotics hub to become a leading surgical robot company in Republic of Korea.

 

“We are delighted that Health Robotics has given us this great opportunity as their exclusive strategic partner in our core market of Korea,” Bum Kyo Lee, CEO of BioRobotics said in a statement. “CytoCare, the world's only real Oncology IV Admixtures Robot in existence, represents an ideal complement to BioRobotics' medical portfolio of Oncology Robotics' products and services, including Intuitive Surgical's daVinci Surgery Robot.”